Curve Biosciences

About Curve Biosciences

Curve Biosciences aims to resolve chronic diseases using Whole-Body Intelligence. They focus on creating molecular blueprints of the body through their Whole-Body Atlas to improve patient monitoring and health outcomes for chronic disease patients.

Products & Services

Whole-Body Blood Tests:Blood tests that monitor organ health of chronic disease patients for optimal accuracy and outcomes, powered by Whole-Body Intelligence models.

Whole-Body Atlas:The largest collection of manually curated tissue samples (>400,000) characterized by organ and disease state, serving as a molecular blueprint of the body.

Specialties

Whole-Body Intelligence Chronic Disease Monitoring Molecular Blueprinting Blood Testing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Funding Round T: - FT: N/A	A: 40000000 MR: - FA: 40 million FAN: 40000000	D: 2025-10-29 FD: 2025-10-29	10 investors

Funding Round Latest

2025-10-29

$40.0M

10 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ritish Patnaik

Chief Executive Officer

LinkedIn (Pro only)

N

Nathan Hunkapiller

Chief Scientific Officer

LinkedIn (Pro only)

A

Alice Chen

Chief Operating Officer

LinkedIn (Pro only)

C

Chuba Oyolu

Chief Technology Officer

S

Shan Wang

Chief Innovation Officer and Scientific Founder

View 2 more team members with Pro

Unlock Full Team Directory

Recent News